Ono Pharmaceutical Co Stock Buy Hold or Sell Recommendation
OPHLF Stock | USD 11.50 0.90 8.49% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Ono Pharmaceutical Co is 'Strong Sell'. Macroaxis provides Ono Pharmaceutical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding OPHLF positions.
Check out Ono Pharmaceutical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Ono and provide practical buy, sell, or hold advice based on investors' constraints. Ono Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Ono |
Execute Ono Pharmaceutical Buy or Sell Advice
The Ono recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ono Pharmaceutical Co. Macroaxis does not own or have any residual interests in Ono Pharmaceutical Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ono Pharmaceutical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Ono Pharmaceutical Trading Alerts and Improvement Suggestions
Ono Pharmaceutical generated a negative expected return over the last 90 days | |
Ono Pharmaceutical has high historical volatility and very poor performance | |
About 16.0% of the company outstanding shares are owned by corporate insiders |
Ono Pharmaceutical Returns Distribution Density
The distribution of Ono Pharmaceutical's historical returns is an attempt to chart the uncertainty of Ono Pharmaceutical's future price movements. The chart of the probability distribution of Ono Pharmaceutical daily returns describes the distribution of returns around its average expected value. We use Ono Pharmaceutical Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ono Pharmaceutical returns is essential to provide solid investment advice for Ono Pharmaceutical.
Mean Return | -0.13 | Value At Risk | -11.55 | Potential Upside | 10.62 | Standard Deviation | 6.51 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ono Pharmaceutical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ono Pharmaceutical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ono Pharmaceutical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ono Pharmaceutical's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ono pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.16 | |
β | Beta against Dow Jones | 1.03 | |
σ | Overall volatility | 8.09 | |
Ir | Information ratio | -0.02 |
Ono Pharmaceutical Volatility Alert
Ono Pharmaceutical Co is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Ono Pharmaceutical's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Ono Pharmaceutical's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Ono Pharmaceutical Fundamentals Vs Peers
Comparing Ono Pharmaceutical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ono Pharmaceutical's direct or indirect competition across all of the common fundamentals between Ono Pharmaceutical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ono Pharmaceutical or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Ono Pharmaceutical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Ono Pharmaceutical by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Ono Pharmaceutical to competition |
Fundamentals | Ono Pharmaceutical | Peer Average |
Return On Equity | 0.16 | -0.31 |
Return On Asset | 0.12 | -0.14 |
Profit Margin | 0.26 % | (1.27) % |
Operating Margin | 0.35 % | (5.51) % |
Current Valuation | 11.13 B | 16.62 B |
Shares Outstanding | 488.31 M | 571.82 M |
Shares Owned By Insiders | 16.04 % | 10.09 % |
Shares Owned By Institutions | 44.41 % | 39.21 % |
Price To Earning | 18.12 X | 28.72 X |
Price To Book | 2.29 X | 9.51 X |
Price To Sales | 0.03 X | 11.42 X |
Revenue | 361.36 B | 9.43 B |
Gross Profit | 267.85 B | 27.38 B |
EBITDA | 123.45 B | 3.9 B |
Net Income | 80.52 B | 570.98 M |
Cash And Equivalents | 136.18 B | 2.7 B |
Cash Per Share | 278.93 X | 5.01 X |
Total Debt | 8.65 B | 5.32 B |
Debt To Equity | 0.01 % | 48.70 % |
Current Ratio | 4.16 X | 2.16 X |
Book Value Per Share | 1,477 X | 1.93 K |
Cash Flow From Operations | 61.83 B | 971.22 M |
Earnings Per Share | 1.74 X | 3.12 X |
Price To Earnings To Growth | 40,587 X | 4.89 X |
Number Of Employees | 3.69 K | 18.84 K |
Beta | 0.26 | -0.15 |
Market Capitalization | 10.62 B | 19.03 B |
Total Asset | 739.2 B | 29.47 B |
Z Score | 0.6 | 8.72 |
Annual Yield | 0.02 % | |
Net Asset | 739.2 B | |
Last Dividend Paid | 28.0 |
Ono Pharmaceutical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ono . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Daily Balance Of Power | 9.2 T | |||
Rate Of Daily Change | 1.08 | |||
Day Median Price | 11.5 | |||
Day Typical Price | 11.5 | |||
Price Action Indicator | 0.45 | |||
Period Momentum Indicator | 0.9 |
About Ono Pharmaceutical Buy or Sell Advice
When is the right time to buy or sell Ono Pharmaceutical Co? Buying financial instruments such as Ono Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ono Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Growth Funds Thematic Idea Now
Large Growth Funds
Funds or Etfs that invest in stocks of large-sized companies with above-average risk and growth rate. The Large Growth Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Growth Funds Theme or any other thematic opportunities.
View All Next | Launch |
Other Information on Investing in Ono Pink Sheet
Ono Pharmaceutical financial ratios help investors to determine whether Ono Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ono with respect to the benefits of owning Ono Pharmaceutical security.